We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
B-cell lymphoma/leukemia 11B (BCL-11B) antibody
B-cell CLL/lymphoma 11B
COUP-TF-interacting protein 2
Radiation-induced tumor suppressor gene 1 protein (hRit1)
Gene name : BCL11B, CTIP2, RIT1
COUP-TF-interacting protein 2
Radiation-induced tumor suppressor gene 1 protein (hRit1)
Gene name : BCL11B, CTIP2, RIT1
As low as
$323.40
In stock
Ref
00014617
Tumor-suppressor protein involved in T-cell lymphomas. May function on the P53-signaling pathway. May be a key regulator of both differentiation and survival during thymocyte development. Repress transcription through direct, TFCOUP2-independent binding to a GC-rich response element
| ID Covalab | pab0574-P |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide derived from Nter domain of common domain of human BCL-11B and BCL-11A |
| Activity cross reaction | Reacts with human 95 kDa protein. Cross reacts with human BCL11A (91 kDa). May cross react with BCL11B & A from mouse and other species, due to the homology. |
| Species | Hu |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | B-cell lymphoma/leukemia 11B (BCL-11B) |
| Uniprot ID | Q9C0K0 |
| Applications | ELISA, IHC, WB |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : - IHC : 1/50 to 1/500 - WB : 1/200 to 1/2 000 |
Write Your Own Review